Blocking inflammation: a new arsenal against atherosclerosis

Endocrinol Diabetes Nutr. 2017 Dec;64(10):515-516. doi: 10.1016/j.endinu.2017.10.003. Epub 2017 Nov 13.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Atherosclerosis / etiology
  • Atherosclerosis / physiopathology
  • Atherosclerosis / prevention & control*
  • C-Reactive Protein / analysis
  • Clinical Trials as Topic
  • Diet, Mediterranean
  • Follow-Up Studies
  • Humans
  • Inflammation / complications
  • Inflammation / diet therapy
  • Inflammation / drug therapy*
  • Inflammation / physiopathology
  • Interleukin-1beta / antagonists & inhibitors*
  • International Cooperation
  • Life Style
  • Multicenter Studies as Topic

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab
  • C-Reactive Protein